Orders from 120 EUR Free delivery from 250 EUR Ready for pickup dead drop: collect in 5 min Free parcel delivery from 250 EUR

Substances · Cathinone derivatives

Eutylone (bk-EBDB)

C13H17NO3 CAS 802855-66-9 Analytical reference material — not for human consumption
Preferred name
Eutylone (bk-EBDB)
IUPAC name
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
Parent CAS number (reference)
802855-66-9
Molecular formula
C13H17NO3
Molecular weight
235.28 g/mol
InChIKey
YERSNXHEOIYEGX-UHFFFAOYSA-N
PubChem
CID 57360686
Source
PubChem
Verified synonyms & catalog abbreviations
Eutylone bk-EBDB N-Ethylbutylone

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

Eutylone (bk-EBDB / N-Ethylbutylone)

Stimulant / Mild Entactogen (Hybrid DAT/NET Blocker & Partial SERT Releaser) Substituted cathinone (3,4-methylenedioxy-N-ethylbutanophenone)
Verified PubChem & CAS Identity C13H17NO3 · CAS 802855-66-9 · CID 57360686
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 235.28 g/mol
Peer-Reviewed & Agency Citations 4 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

Hybrid monoamine transporter compound (Glatfelter et al., 2021; WHO 44th ECDD): acts as an uptake blocker at DAT (rat IC50 = 120 ± 10 nM; human hDAT IC50 = 281 ± 80 nM) and NET (rat IC50 = 1,280 ± 140 nM; human hNET IC50 = 700 ± 100 nM), while acting as a weak partial substrate releaser at SERT reaching only 50% of maximal response (human hSERT IC50 = 640 ± 160 nM). This explains why eutylone yields a modest, short-lived MDMA-like warm glow followed by hours of pure dopaminergic/adrenergic stimulation.

Biotransformation & Active Metabolites

Metabolized via beta-ketone reduction, CYP2D6/CYP2C19-catalyzed demethylenation of the benzodioxole ring, COMT O-methylation, and Phase II conjugation. Also promotes antidiuretic hormone (ADH) release, causing temporary urinary difficulty and hyponatremia risk if excess water is consumed.

Temporal Pharmacokinetics

Energetic, sociable cathinone combining a brief, mild entactogenic body tingle and conversational openness with a long, insistent catecholaminergic stimulant tail.

  1. Onset 15–45 minutes oral (5–15 minutes mucosal)
  2. Peak Window 1–2 hours oral (30–60 minutes mucosal)
  3. Total Window 4–8 hours oral (DEA reports effects lasting up to 8 hours; mucosal primary phase 1.5–3 hours)
  4. Residual / Half-Life 2–24 hours of persistent wakefulness, insomnia, and fatigue; in vivo human elimination half-life is unverified.

Major repeated exposure trap: eutylone's mild empathogenic glow fades rapidly because SERT release caps at 50% maximal efficacy. 'Piggy-backing' extra doses to chase a stronger MDMA-like roll stacks long-lasting DAT/NET blockade—causing up to 8–24 hours of sleeplessness, agitation, tachycardia, rhabdomyolysis, seizures, and documented single-use fatalities as amounts approach or exceed 200 mg.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
35 mg
Cognitive & Sensory

Subtle wakefulness, light mood lift, and mild conversational ease.

Somatic & Autonomic

Slight dry mouth and gentle increase in pulse.

Light
40–60 mg
Cognitive & Sensory

Sociable energy, talkativeness, modest emotional warmth, and music enhancement.

Somatic & Autonomic

Moderate heart-rate rise, light sweating, and appetite suppression.

Common Reference
60–100 mg (WHO forum reports up to 100–200 mg oral; ~50 mg mucosal)
Cognitive & Sensory

Clear mood elevation, social disinhibition, warm tactile tingling transitioning into alert dopaminergic stimulation.

Somatic & Autonomic

Elevated heart rate and blood pressure, dry mouth, moderate jaw tension, and ADH-mediated difficulty urinating.

Strong
100–180 mg
Cognitive & Sensory

Forced physical restlessness, vibrating vision (nystagmus), hand unsteadiness, anxiety on offset, and persistent inability to sleep.

Somatic & Autonomic

Strong tachycardia, hypertension, bruxism, hyperthermia in hot environments, and water-intoxication risk if over-drinking.

Heavy / Toxic Zone
180–200+ mg (counterfeit street tablets seized at 300–350 mg linked to severe poisonings)
Cognitive & Sensory

Acute panic, paranoia, visual hallucinations, agitated delirium, and stimulant psychosis.

Somatic & Autonomic

Severe hyperthermia, rhabdomyolysis, hypertension, tonic-clonic seizures, and documented fatal intoxication.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Partial SERT release plus DAT/NET blockade under MAO inhibition triggers fatal serotonin syndrome, hyperpyrexia, and hypertensive crisis.

MDMA, 4-MMC, 3-MMC, 5-MAPB, 6-APB, Tramadol, and DXM

Synergistic serotonergic and adrenergic overload precipitates hyperthermia, seizures, rhabdomyolysis, and serotonin toxicity.

Opioids (Fentanyl, O-DSMT), Cocaine, Pyrovalerones, NEP, Hexen, and 25x-NBOMe

Opioid co-ingestions account for fatal eutylone overdoses; co-stimulants cause severe hypertension, vasoconstriction, and seizures.

Elevated Hazard — Avoid

Excessive plain water intake (over-hydration) or Alcohol

Eutylone promotes ADH release (urinary retention); chugging excessive water causes dangerous water intoxication (hyponatremia), while alcohol worsens overheating and cardiac strain.

CYP2D6 / CYP2C19 inhibitors

Impairs hepatic demethylenation of eutylone, prolonging cardiovascular stimulation and insomnia.

Caution / Receptor Attenuation

SSRIs and SNRIs

Blunts eutylone's already modest partial SERT warmth while leaving long-lasting adrenergic wakefulness intact.

Cannabis

Can heighten heart rate and trigger anxious thought loops during eutylone's protracted offset.

Structural Isomer & Sibling Comparison

Compared to 4-MMC and 3-MMC (full monoamine releasers), eutylone is a hybrid DAT/NET blocker and only a 50%-efficacy partial SERT releaser: its warm 'rolly' phase is noticeably milder and shorter than 4-MMC, while its wakeful stimulant tail lasts longer (up to 8 hours). Compared to MDPHP (which also has a 3,4-methylenedioxy ring), eutylone is ~3-fold gentler per milligram (common 60–100 mg vs. 20–35 mg) and retains mild serotonergic warmth that MDPHP lacks.

Physicochemical Stability & Storage

Form: Odorless crystalline solid or crystals as the hydrochloride salt. · Soluble in water, methanol, and ethanol as the hydrochloride salt.

High analytical stability due to the 3,4-methylenedioxy group (blood sample t1/2 of 31 days at 20 °C in vitro); store dry and protected from light.

Cross-Tolerance & Dependence Profile

Cross-tolerant with all dopaminergic and serotonergic stimulants (4-MMC, 3-MMC, MDMA, NEP); tolerance halves in 3–7 days and resets in 1–2 weeks. High risk of compulsive 'piggy-back' repeated exposure; withdrawal after heavy use involves ~1 week of exhaustion, headaches, tremors, sweating, and low mood.

Comprehensive Analytical & Toxicological Monograph

Eutylone (bk-EBDB / N-ethylbutylone; 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one; freebase CAS 802855-66-9, hydrochloride CAS 17764-18-0, PubChem CID 57360686) is a 3,4-methylenedioxy-substituted cathinone queued in weekly synthesis slot #15 as pure analytical crystals or crystalline powder (C13H17NO3, 235.28 g/mol). Pharmacological characterization by NIDA and the WHO 44th ECDD reveals a distinctive hybrid mechanism: eutylone blocks dopamine and norepinephrine reuptake (hDAT IC50 = 281 nM, hNET IC50 = 700 nM) without inducing catecholamine release, while acting as a weak partial substrate releaser at the serotonin transporter capped at 50% maximal response (hSERT IC50 = 640 nM). According to WHO ECDD and clinical toxicology reports, oral threshold effects begin at 35 mg, light sociable stimulation spans 40–60 mg, average/common balanced effects sit at 60–100 mg (mucosal ~50 mg), strong forced stimulation with nystagmus and bruxism occurs at 100–180 mg, and exposures nearing or exceeding 180–200 mg sharply elevate risks of hyperthermia, rhabdomyolysis, seizures, and documented fatalities. Oral onset takes 15–45 minutes; crucially, while the warm entactogenic peak subsides early, catecholaminergic stimulation can persist up to 8 hours followed by protracted insomnia. 'Piggy-backing' extra doses to chase a deeper MDMA-like 'roll' cannot overcome the 50% SERT ceiling and instead stacks sleepless adrenergic toxicity. Because eutylone promotes antidiuretic hormone (ADH) release, users should sip water modestly rather than over-drinking. Compared to 4-MMC, eutylone is milder emotionally with a longer wakeful tail; compared to MDPHP, it is gentler per milligram and retains mild serotonergic warmth. Never mix with MAOIs, MDMA/4-MMC, tramadol, DXM, opioids, cocaine, pyrovalerones, or 25x-NBOMe.

Chemical Architecture & Structural Profile

Eutylone (bk-EBDB) (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one) is a reference compound belonging to the Cathinone derivatives class, characterized by the molecular formula C13H17NO3 and a molar mass of 235.28 g/mol. The parent molecule is indexed under CAS registry number 802855-66-9 and in the NCBI PubChem database as CID 57360686 (Standard InChIKey: YERSNXHEOIYEGX-UHFFFAOYSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), Eutylone (bk-EBDB) is indexed within the Cathinone derivatives structural group. As a substituted beta-ketone (cathinone derivative), this compound requires strict analytical verification and has documented contraindications with MAOIs, serotonergic agents, and other stimulants. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations